Key result
Low care quality was associated with a significantly higher risk of death at 30 days (HR 7.0), 1 year (HR 4.0), and 5 years (HR 2.6) compared to optimum care in STEMI patients with cancer.
Why the study?
While clinical outcomes of STEMI are worse in patients with cancer, the role of in-hospital care quality was unknown.
Does optimum care quality improve survival in STEMI patients with cancer?
Cohort (n=6,787)
Yes
Does optimum care quality improve survival in STEMI patients with cancer?
In STEMI patients with cancer, receiving optimal guideline-directed care is strongly associated with improved short- and long-term survival, highlighting a critical area for quality improvement.
BACKGROUND: While current evidence suggests that the clinical outcomes of ST-elevation myocardial infarction (STEMI) are worse among patients with cancer, it is unknown what role the quality of care received during admission plays. We aimed to evaluate the association between care quality and patient survival after discharge. METHODS AND RESULTS: A nationally-linked cohort of STEMI patients (January 2005-March 2019) were obtained from the UK Myocardial Infarction National Audit Project and UK national Hospital Episode Statistics Admitted Patient Care registries. We used the composite opportunity-based quality indicator to measure overall care quality. Survival outcomes were assessed using Cox proportional hazard models and Kaplan-Meier and cumulative survival curves. In total, 6787 STEMI indexed admissions with cancer were identified. Of those, 4340 (63.9%) patients received optimum care, 1320 (19.5%) intermediate care, and 1127(25.2%) low care quality. Patients with low care quality were older [optimum quality median (IQR) = 72.8 (65.1, 79.6), intermediate quality 75.5 (67.9, 82.1), low quality 78.2 (69.2, 84.7)] and more frequently women (optimum quality 21.6%, intermediate quality 27.3%, low quality 35.5%). Compared to patients with optimum care, patients with low care quality had a higher risk of death at 30 days [hazard ratio (HR) 7.0, 95% confidence interval (CI) 5.7-8.7], 1 year (HR 4.0, 95% CI 3.6-4.4), and 5 years (HR 2.6, 95% CI 2.4-2.8). Relative survival analysis revealed that the number of patients who would survive nationally if they received optimal care is 84 (95% CI 67-102), 508 (95% CI 468-548), and 1096 (95% CI 1034-1158) at 30 days, 1 year, and 5 years, respectively. The association between care quality and survival was more profound in the Northwest and Northeast regions. CONCLUSION: Quality of care is closely associated with short- and long-term survival among STEMI patients with cancer. Improving quality of care may save hundreds to thousands of lives in the shorter and longer term.
No takes yet. Share an insight, caveat, or question.
Dafaalla et al. (2025) conducted a cohort in ST-elevation myocardial infarction with cancer (n=6,787). Low care quality vs. Optimum care quality was evaluated on All-cause mortality at 30 days (HR 7.0, 95% CI 5.7-8.7). Low care quality was associated with a significantly higher risk of death at 30 days (HR 7.0), 1 year (HR 4.0), and 5 years (HR 2.6) compared to optimum care in STEMI patients with cancer.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: